TrialJournal of neuro-oncology2016

Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial.

Carmen Balana et al.PubMed ↗Publisher ↗

No numbers read from the abstract.